{
  "catalogId": "91b0f417-2454-464f-b0a5-cef76928b60c",
  "name": "IMBRUVICA 560 MG TABLETS",
  "status": "draft",
  "category": "prescription",
  "registrationValidity": "valid",
  "registrationNumber": "167 64 36461 99",
  "treatmentDescriptions": "•\tMantle Cell Lymphoma:Imbruvica is indicated for the treatment of adult patients with mantle cell lymphoma (MCL) who have received at least one prior therapy.•\tChronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma :Imbruvica is indicated for the treatment of adult patients, with chronic lymphocytic leukemia (CLL)/Small lymphocytic lymphoma (SLL)•\tChronic Lymphocytic Leukemia (CLL) /Small Lymphocytic Lymphoma (SLL) with 17p deletion:Imbruvica is indicated for the treatment of adult patients with chronic lymphocytic leukemia (CLL)  /Small Lymphocytic Lymphoma (SLL) with 17p deletion.•\tWaldenström’s MacroglobulinemiaImbruvica is indicated for the treatment of adult patients with Waldenström’s macroglobulinemia (WM).•\tMarginal Zone LymphomaIMBRUVICA is indicated for the treatment of adult patients with marginal zone lymphoma (MZL) who require systemic therapy and have received at least one prior anti-CD20-based therapy.•\tChronic Graft versus Host DiseaseIMBRUVICA is indicated for the treatment of adult patients with chronic graft-versus-host disease (cGVHD) after failure of one or more lines of systemic therapy.",
  "termsOfIssue": "Prescription required",
  "form": "film coated tablets",
  "route": "per os",
  "site": "",
  "method": "",
  "administrationNotes": "",
  "ingredients": "IBRUTINIB",
  "codes": {
    "atc5": {
      "system": "WHO ATC Classification",
      "code": "L01XE27",
      "name": "IBRUTINIB"
    }
  },
  "contraindications": "",
  "sideEffect": "",
  "warnings": "תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ",
  "alternativeMedications": [],
  "packaging": [
    {
      "name": "IMBRUVICA 560 MG 30 FILM COATED TABLETS",
      "manufacturer": {
        "name": "יאנסן סילג",
        "countryOfOrigin": "IL"
      },
      "strength": [
        {
          "value": 560.0,
          "unit": "mg"
        }
      ],
      "quantity": {
        "value": 30.0,
        "unit": "units"
      },
      "packagingDescription": "BLISTER PVC/PCTFE/AL",
      "shelfLife": "24",
      "storageConditions": "",
      "codes": {
        "moh": "9155",
        "yarpa": "74058",
        "pharmasoft": "9155",
        "barcode": "7290014577688"
      },
      "manufacturersAdministrationRecommendation": "",
      "pricing": {
        "currency": "ILS",
        "maxWholesalePrice": 24907.40437,
        "retailMargin": 10.0,
        "maxRetailPrice": 27398.1448,
        "maxPriceWithVAT": 32329.80943
      },
      "formulation": [
        "tablet"
      ]
    }
  ],
  "metadata": {
    "version": "1.5",
    "lastUpdated": "2025-08-01T18:03:51.854774",
    "tags": [],
    "smartValidation": {
      "extractedFrom": "IMBRUVICA 560 MG 30 FILM COATED TABLETS",
      "processedBy": "smart_validation",
      "matchScore": 0.9785714285714286,
      "status": "corrected",
      "correctedAt": "2025-08-01T16:07:33.350116",
      "previousRegistration": "167 61 36458 99",
      "newRegistration": "167 64 36461 99",
      "apiSource": "IMBRUVICA 560 MG TABLETS"
    }
  },
  "nameHebrew": "אימברוביקה 560 מ\"ג טבליות",
  "registrationDate": "2021-06-22"
}